The decline in the SP is most likely due to the uncertainty of the BARDA procurement. Hopefully they are negotiating it for this quarter.Also, the quarterly not giving any info on the numbers that have are being shipped and the number hospitals ordering.
- Forums
- ASX - By Stock
- AVH
- How do you lose 36% after FDA approval?
How do you lose 36% after FDA approval?, page-2
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.80 |
Change
-0.030(1.06%) |
Mkt cap ! $197.1M |
Open | High | Low | Value | Volume |
$2.83 | $2.89 | $2.80 | $299.8K | 105.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3700 | $2.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.83 | 10724 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 2.790 |
1 | 2400 | 2.780 |
1 | 500 | 2.770 |
1 | 2000 | 2.760 |
1 | 4000 | 2.750 |
Price($) | Vol. | No. |
---|---|---|
2.830 | 10724 | 2 |
2.870 | 14722 | 3 |
2.880 | 14249 | 3 |
2.890 | 9500 | 1 |
2.900 | 5050 | 4 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online